Inhibikase Therapeutics Inc (IKT) — Defensive Interval Ratio
Inhibikase Therapeutics Inc (IKT) has a Defensive Interval Ratio of 2129 days as of September 2025. Defensive assets of $39.05 Million (cash $-, short-term investments $39.05 Million, receivables $-) cover 2129 days of daily cash needs of $18.35K/day. For the complete balance sheet picture, see IKT total assets.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Inhibikase Therapeutics Inc Defensive Interval Ratio (2016–2024)
This chart shows how Inhibikase Therapeutics Inc's Defensive Interval Ratio has evolved across 8 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 2129 days, meaning defensive assets of $39.05 Million can fund 2129 days of operations without new revenue. Check IKT asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Annual Defensive Interval Ratio for Inhibikase Therapeutics Inc (2016–2024)
The table below presents the year-by-year Defensive Interval Ratio for Inhibikase Therapeutics Inc from 2016 to 2024, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 4013 days | $41.05 Million | $10.23K/day | $- | $41.05 Million | ▲ +3575 days |
| 2023 | 438 days | $4.13 Million | $9.42K/day | $- | $4.09 Million | ▼ -1133 days |
| 2022 | 1571 days | $15.90 Million | $10.12K/day | $- | $15.86 Million | ▲ +1561 days |
| 2021 | 10 days | $110.14K | $11.11K/day | $- | $0.00 | ▲ +10 days |
| 2020 | 0 days | $0.00 | $12.94K/day | $- | $- | ▼ -48 days |
| 2018 | 48 days | $472.94K | $9.93K/day | $- | $- | ▲ +9 days |
| 2017 | 38 days | $180.78K | $4.73K/day | $- | $- | ▲ +22 days |
| 2016 | 16 days | $66.88K | $4.15K/day | $- | $- | — |